基于中医传承辅助系统探讨丁治国教授治疗甲状腺功能亢进症的用药规律

doi:10.20047/j.issn1673-7210.2023.28.04

Abstract
Figure/Table
References (27)
Related Citation (15)

Download: PDF (1205 KB) HTML (1 KB)
Export: BibTeX | EndNote (RIS)

Abstract Objective To explore the prescription and medication rule of Professor Ding Zhiguo in the treatment of hyperthyroidism with the traditional Chinese medicine inheritance assistance system (V2.5) software. Methods Traditional Chinese medicine prescriptions for the treatment of hyperthyroidism issued by Professor Ding Zhiguo in the thyroidology outpatient Department of Thyropathy Dongzhimen Hospital, Beijing University of Chinese Medicine from July 2019 to November 2020 were collected and a database was established. Frequency statistics, association rules, and so on were used for data mining to analyze and study the core drugs and their nature, flavour, channel tropism, and prescription formation laws. Results A total of 197 prescriptions meeting the criteria were screened out, involving 84 kinds of traditional Chinese medicine, and 22 drugs with frequency ≥110 in the prescriptions. The main channel tropism of drugs were liver and lung channels. The nature and flavour of drugs were bitter and cold respectively. There were 33 couplet medicines with frequency ≥180 and 19 groups of three medicines with frequency ≥185. There were six core prescriptions, six new formula core combinations, and three new prescriptions. The core prescriptions were: Prunellae Spica, Albiziae Flos, Ranunculi Ternati Radix, Bupleuri Radix, Cyperi Rhizoma, Os Draconis, Ostreae Concha, Scutellariae Radix, Platycodonis Radix, Moutan Cortex, Polygoni Multiflori Caulis, Anemarrhenae Rhizoma, Gypsum Fibrosum, Astragali Radix, Paeoniae Radix Rubra, Salviae Miltiorrhizae Radix Et Rhizoma, Taraxaci Herba, Belamcandae Rhizoma, Alismatis Rhizoma, Paeoniae Radix Alba, Margaritifera Concha, Ziziphi Spinosae Semen. Conclusion Professor Ding Zhiguo’s treatment of hyperthyroidism is based on the theory of “Yeben Xiangying”. He is good at using bitter and cold drug to improve the warm-heat disease caused by hyperthyroidism, combined with sweet drug to regulate and tonify qi, blood, yin and yang, sooth liver and strengthen spleen, regulate liver and lung, and treat both symptoms and root causes.

Key words： Hyperthyroidism Traditional Chinese medicine inheritance assistance system Medication rule Traditional Chinese medicine

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	GE Yaxue1 CHEN Xiaoheng1 QI Shuo2 LI Zhe1 LI Huilong1 LIU Meijun1 DING Zhiguo2

Cite this article:

GE Yaxue1 CHEN Xiaoheng1 QI Shuo2 LI Zhe1 LI Huilong1 LIU Meijun1 DING Zhiguo2. Exploration of the medication rule for the use of Ding Zhiguo in the treatment of hyperthyroidism based on traditional Chinese medicine inheritance assistance system[J]. 中国医药导报, 2023, 20(28): 20-25.

URL:

https://www.yiyaodaobao.com.cn/EN/10.20047/j.issn1673-7210.2023.28.04 OR https://www.yiyaodaobao.com.cn/EN/Y2023/V20/I28/20

[1] 向光大.临床甲状腺病学[M].北京：人民卫生出版社，2013：108.
[2] Li Y，Teng D，Ba J，et al. Efficacy and Safety of Long-Term Universal Salt Iodization on Thyroid Disorders: Epidemiological Evidence from 31 Provinces of Mainland China [J]. Thyroid，2020，30（4）：568-579.
[3] 田德禄.中医内科学[M].北京：人民卫生出版社，2002：286-287.
[4] 杨硕，李敏，李金峰，等.甲状腺功能亢进症行中西医结合疗法治疗的临床疗效与安全性分析[J].中国全科医学，2020，23（S1）：201-203.
[5] 廖为保，刘怀珍，王慧慧，等.中医药防治弥漫性毒性甲状腺肿的临床研究进展[J].江西中医药大学学报，2020， 32（4）：120-124.
[6] 李凤敏.甲状腺功能亢进症的中西医治疗进展[J].内蒙古中医药，2019，38（5）：150-152.
[7] 中华医学会内分泌学分会《中国甲状腺疾病诊治指南》编写组.中国甲状腺疾病诊治指南——甲状腺功能亢进症[J].中华内科杂志，2007，46（10）：876-882.
[8] 国家药典委员会.中华人民共和国药典[S].一部.北京：中国医药科技出版社，2020.
[9] 尹谢添，赵诗超，向楠，等.基于JNK/p38 MAPK信号通路探讨夏枯草胶囊对自身免疫性甲状腺炎大鼠的作用[J].中成药，2022，44（12）：3817-3823.
[10] 张红，耿辉，曲海丽，等.夏枯草水提液对自身免疫性甲状腺炎大鼠5-HT和Th17的影响[J].天津中医药大学学报，2022，41（4）：484-491.
[11] 杨慧珍，李映，葛喜珍.夏至草、益母草及夏枯草的化学成分及药理作用研究进展[J].北京联合大学学报，2021， 35（2）：85-92.
[12] 张金华，邱俊娜，王路，等.夏枯草化学成分及药理作用研究进展[J].中草药，2018，625（14）：245-253.
[13] 唐永和，梁莹莹，王海洋，等.夏枯草治疗甲状腺疾病的临床应用及药理作用研究进展[J].中日友好医院学报，2020，34（3）：176-178.
[14] 李冉，田介峰，罗学军，等.合欢花的化学成分及其药理作用的研究进展[J].天津药学，2022，34（2）：66-71.
[15] 赵文秀，马骏，李文基，等.猫爪草多糖研究进展[J].甘肃中医药大学学报，2020，37（4）：87-90.
[16] 张丽华，王元春，龚菁，等.猫爪草对肺结核患者肝功能的调控作用[J].中国当代医药，2022，29（9）：11-14.
[17] 潘少斌，孔娜，李静，等.香附化学成分及药理作用研究进展[J].中国现代中药，2019，21（10）：1429-1434.
[18] 张晶，刘莉，徐慧荣，金娟.香附化学成分及药理作用研究新进展[J].化学工程师，2021，35（3）：55-57.
[19] 李心爱，张旭帆，袁姣姣，等.基于网络药理学探讨香附治疗桥本氏病作用机制[J].中国医药科学，2023，13（11）：42-46.
[20] 袁敏皎，袁捷，韩祖成.基于中医传承辅助平台挖掘中医药治疗卒中后抑郁的用药规律[J].中国医药导报，2021， 18（5）：159-162.
[21] 李梃.医学入门[M].南昌：江西科学技术出版社，1988.
[22] 葛亚雪，祁烁，陈晓珩，等.丁治国教授基于“木郁达之”理论论治甲状腺功能亢进症的经验总结[J].中国医药导报，2020，17（32）：120-123.
[23] 管傲然，管薇薇，丁丽玲，等.“肝生于左，肺藏于右”[J].实用中医内科杂志，2013，27（15）：45-46.
[24] 倪青.甲状腺功能亢进症病证结合诊疗指南（2021-01- 20）[J].世界中医药，2021，16（2）：193-196.
[25] 王艳苹.甘寒归肝肾经中药药性研究-对免疫功能低下小鼠免疫功能的影响[D].合肥：合肥工业大学，2007.
[26] 金李，谷帮杰，李传芝，等.中药寒热药性与其现代药理作用关联研究[J].亚太传统医药，2020，16（6）：161-163.
[27] 丁治国.靥本相应论：甲状腺疾病中医诊疗新思路[M].北京：清华大学出版社，2021：48.